Efficacy of the Triazole SCH 56592 against Leishmania amazonensis and Leishmania donovani in Experimental Murine Cutaneous and Visceral Leishmaniases

Current therapy for leishmaniasis is unsatisfactory. Efficacious and safe oral therapy would be ideal. We examined the efficacy of SCH 56592, an investigational triazole antifungal agent, against cutaneous infection with Leishmania amazonensis and visceral infection with Leishmania donovani in BALB/...

Ausführliche Beschreibung

Bibliografische Detailangaben

Veröffentlicht in:	Antimicrob Agents Chemother
Hauptverfasser:	Al-Abdely, Hail M., Graybill, John R., Loebenberg, David, Melby, Peter C.
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	American Society for Microbiology (ASM) 1999
Schlagworte:	Experimental Therapeutics
Online-Zugang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC89586/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10582881/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.43.12.2910
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!